ABMD - ABIOMED Charts, Trade Ideas, Earnings, Ratings

TRENDING : Top 50 SPY (1.05%) PTON (0.42%) GPRO (3.01%) AGRX (14.96%) NVAX (-15.65%) AAPL (2.83%) AAOI (-2.42%) LEDS (0.5%) LAKE (-13.05%) JPM (1.82%) JNJ (0.51%) JEF (1.17%) INTC (2.47%) HOME (2.25%) HEXO (-0.76%) HAL (1.99%) FDX (-0.07%) FB (1.36%) ENDP (-2.93%) ELOX (-1.73%) CVX (0.67%) CVM (6.94%) CMCSA (0.1%) BTCUSD (%) BABA (2.32%)

ABMD - ABIOMED

$187.01 5.56[3.07%]

15 mins delayed data

People also watch : ATRC | BSX | STXS | TFX

+Watchlist

4 StockHoot Traders following this.
Analyst Ratings | Earnings

Previous Close	$181.45	Open	$182.26
Volume	592.5K	Market Cap	12.021B
Yield		Last Dividend

Day

52 Week

ABIOMED (ABMD) Announces Preliminary Q3 ...	01/14/20
ABIOMED's (ABMD) Q3 international revenues grew year over year; fiscal 2020 view slashed.

10 Worst Performing S&P 500 Stocks Of 20...	12/24/19
The S&P 500 had another big year this year, gaining more than 28% year to date. Most U.S. investors had a lot of winners in their portfolios this year...

Global Ventricular Assist Devices Market...	12/03/19
LONDON--(BUSINESS WIRE)-- #Healthcare--Global ventricular assist devices market is poised to grow by USD 943.27 million during 2020-2024 at a CAGR of ...

Abiomed Medical Office Completes Review ...	11/19/19
Abiomed (NASDAQ: ABMD ) is committed to improving patient outcomes by performing FDA studies and post-market surveillance, collecting real-world evide...

Abiomed (ABMD) Earnings Expected to Grow...	10/24/19
Abiomed (ABMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with t...

Hedge Funds Aren???t Crazy About ABIOMED...	10/20/19
Does ABIOMED, Inc. (NASDAQ:ABMD) represent a good buying opportunity at the moment? Let???s quickly check the hedge fund interest towards the company....

The Daily Biotech Pulse: UCB To Buy Ra P...	10/10/19
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting 52-week highs on Oct. 9) A...

The Daily Biotech Pulse: FDA Approves Cl...	10/09/19
The following is a roundup of top developments in the biotech space over the last 24 hours. None of the NYSE or Nasdaq-listed biotech stocks hit 52-we...

Abiomed's (ABMD) Impella 5.5 With SmartA...	10/02/19
Abiomed's (ABMD) flagship Impella heart pump line is a major growth driver.

The Daily Biotech Pulse: ESMO Conference...	09/27/19
The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs S...

ANALYST RATINGS

2 analyst ratings (Last 6 months)

0.00 %

Strong Buy + Buy

Price Target (PT)

Hold rating	12/17/19
Morgan Stanley maintains Equal-Weight rating and lowers Price Target from $215.00 to $198.00

Hold rating	08/02/19
Morgan Stanley downgrades from Overweight to Equal-Weight rating and lowers Price Target from $325.00 to $215.00

EARNINGS

Date	2019-10-31 (BMO)	Est. (EPS/Rev.)	$0.93/ 206.45M
Actual (EPS/Rev.)	$1.03/ $204.97 M	EPS (TTM)	0

TRADERS TRACKING $ABMD

Service Name	Trader	% Success
MA MA MIA	Hao	60.00 %	Subscribe
Market Focus	Hao	60.00 %	Subscribe
TopFlight Trades - Premium (Options)	Eric Cunningham	50.00 %	Follow
Silent swinger	hasmat	49.00 %	Follow
Seattle Stock Technical Breakout Plays	Les	49.00 %	Follow

SHOW ALL TRADERS

About Us

Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.

Product Types

Strategies

Follow Us

Secure Payments

We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.